NPI: 1376844308 · ENTERPRISE, AL 36330 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/08/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/08/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,215 | $31K |
| 2019 | 3,940 | $90K |
| 2020 | 11,137 | $199K |
| 2021 | 6,777 | $183K |
| 2022 | 13,064 | $176K |
| 2023 | 7,039 | $147K |
| 2024 | 1,183 | $38K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,736 | 1,159 | $623K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,616 | 732 | $201K |
| J1756 | Injection, iron sucrose, 1 mg | 3,299 | 527 | $16K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 246 | 93 | $12K |
| 83970 | 228 | 173 | $4K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,316 | 355 | $2K |
| A4657 | Syringe, with or without needle, each | 506 | 405 | $1K |
| 82108 | 51 | 41 | $734.41 | |
| 83550 | 152 | 123 | $540.50 | |
| 82728 | 137 | 110 | $484.74 | |
| 85041 | 430 | 375 | $481.19 | |
| 85048 | 403 | 355 | $432.75 | |
| 83540 | 152 | 123 | $354.94 | |
| 90674 | 29 | 24 | $180.59 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 54 | 28 | $0.00 |